Skip to content

A Study on Vallarai Chooranam in the management of Azhal Neerchurukku(Urinary Tract Infection)

SINGLE CENTRIC NON RANDOMISED OPEN CLINICAL TRIAL PHASE II IN AZHAL NEERCHURUKKU(URINARY TRACT INFECTION)WITH SIDDHA MEDICINE VALLARAI CHOORANAM AMONG PATIENTS ATTENDING OPD AT GOVERNMENT SIDDHA MEDICAL COLLEGE HOSPITAL,CHENNAI - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086184
Enrollment
40
Registered
2025-05-02
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

Intervention1: Vallarai Chooranam: The medicine will be given 1.5 gms,twice a day for 40 days with Ghee Control Intervention1: Nil: Nil

Sponsors

Government Siddha Medical College, Chennai
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having complaints such as Dysuria, Frequency of micturition, Burning micturition, Hematuria , Lower abdominal pain, Low backache / supra pubic pain, patients with urine culture significant for bacteria or fungus,Patients having moderate to severe symptoms according to UTI symptom assessment scale

Exclusion criteria

Exclusion criteria: Pregnancy H/O Sexually transmitted disease H/O Malignancy H/O Diabetes mellitus

Design outcomes

Primary

MeasureTime frame
It is mainly assessed by reduction in Clinical Signs and Symptoms by UTI Symptom assessment score and also assessed by Urine Culture when bacterial/fungal infection becomes negative after treatmentTimepoint: 40 days

Secondary

MeasureTime frame
By Comparing the Clinical Signs and Symptoms and the Urine Culture before and after treatmentTimepoint: 40 days

Countries

India

Contacts

Public ContactDr Sudhamathi Pushparaj

Government Siddha Medical College,Chennai

sudhamathipushparaj@gmail.com9445118473

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026